Arcellx (ACLX) Stock Forecast, Price Target & Predictions
ACLX Stock Forecast
Arcellx stock forecast is as follows: an average price target of $61.00 (represents a -20.67% downside from ACLX’s last price of $76.89) and a rating consensus of 'Buy', based on 7 wall street analysts offering a 1-year stock forecast.
ACLX Price Target
The average price target for Arcellx (ACLX) is $61.00 based on 1-year price targets from 7 Wall Street analysts in the past 3 months, with a price target range of $85.00 to $32.00. This represents a potential -20.67% downside from ACLX's last price of $76.89.
ACLX Analyst Ratings
According to 7 Wall Street analysts, Arcellx's rating consensus is 'Buy'. The analyst rating breakdown for ACLX stock is 0 'Strong Buy' (0.00%), 7 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Arcellx Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| May 31, 2024 | Biren Amin | Piper Sandler | $70.00 | $52.24 | 34.00% | -8.96% |
| May 15, 2024 | Benjamin Burnett | Stifel Nicolaus | $83.00 | $50.62 | 63.97% | 7.95% |
| May 13, 2024 | Cory Kasimov | Evercore ISI | $85.00 | $49.77 | 70.79% | 10.55% |
| Mar 18, 2024 | Gil Blum | Needham | $81.00 | $69.11 | 17.20% | 5.35% |
| Dec 12, 2022 | - | Needham | $35.00 | $28.84 | 21.34% | -54.48% |
| Dec 12, 2022 | - | Barclays | $38.00 | $28.02 | 35.62% | -50.58% |
| Jul 20, 2022 | John Newman | Canaccord Genuity | $32.00 | $18.27 | 75.15% | -58.38% |
| Jun 23, 2022 | - | Leerink Partners | $38.00 | $15.65 | 142.81% | -50.58% |
The latest Arcellx stock forecast, released on May 31, 2024 by Biren Amin from Piper Sandler, set a price target of $70.00, which represents a 34.00% increase from the stock price at the time of the forecast ($52.24), and a -8.96% decrease from ACLX last price ($76.89).
Arcellx Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 4 |
| Avg Price Target | - | - | $79.75 |
| Last Closing Price | $76.89 | $76.89 | $76.89 |
| Upside/Downside | -100.00% | -100.00% | 3.72% |
In the current month, the average price target of Arcellx stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Arcellx's last price of $76.89. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Sep 03, 2024 | Cantor Fitzgerald | - | Overweight | Initialise |
| Jul 22, 2024 | Piper Sandler | Buy | Buy | Hold |
| Jul 22, 2024 | Needham | Underperform | Underperform | Hold |
| Jun 18, 2024 | Piper Sandler | Buy | Buy | Hold |
| Jun 18, 2024 | Needham | Underperform | Underperform | Hold |
| May 31, 2024 | Stifel Nicolaus | Buy | Buy | Hold |
| May 31, 2024 | Piper Sandler | - | Overweight | Initialise |
| May 14, 2024 | Needham | Buy | Buy | Hold |
| May 13, 2024 | Evercore ISI | - | Outperform | Initialise |
| Mar 07, 2024 | Morgan Stanley | - | Overweight | Initialise |
Arcellx's last stock rating was published by Cantor Fitzgerald on Sep 03, 2024. The company Initialise its ACLX rating from "null" to "Overweight".
Arcellx Financial Forecast
Arcellx Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $63.15M | $14.96M | $14.30M | $17.91M | - |
| Avg Forecast | $27.38M | $27.38M | $27.38M | $27.38M | $35.75M | $21.96M | $20.63M | $20.63M | $27.76M | $37.13M | $22.04M | $20.67M | $20.07M | $17.49M | $39.29M | $100.97M | $3.00M |
| High Forecast | $70.27M | $70.27M | $70.27M | $70.27M | $91.73M | $56.34M | $52.94M | $52.94M | $71.22M | $71.71M | $56.54M | $53.03M | $25.12M | $44.89M | $100.81M | $259.09M | $7.70M |
| Low Forecast | $8.60M | $8.60M | $8.60M | $8.60M | $11.23M | $6.90M | $6.48M | $6.48M | $8.72M | $19.61M | $6.92M | $6.49M | $15.07M | $5.49M | $12.34M | $31.71M | $942.21K |
| # Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 8 | 5 | 4 | 7 | 5 | 6 | 3 | 2 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 3.15% | 0.86% | 0.36% | 0.18% | - |
Arcellx's average Quarter revenue forecast for Mar 24 based on 4 analysts is $20.67M, with a low forecast of $6.49M, and a high forecast of $53.03M. ACLX's average Quarter revenue forecast represents a -67.27% decrease compared to the company's last Quarter revenue of $63.15M (Dec 23).
Arcellx EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 8 | 5 | 4 | 7 | 5 | 6 | 3 | 2 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $35.76M | $-44.86M | $-29.56M | $-25.56M | $-35.29M |
| Avg Forecast | $17.55M | $17.55M | $17.55M | $17.55M | $22.91M | $14.07M | $13.22M | $13.22M | $17.78M | $23.79M | $14.12M | $13.24M | $12.86M | $11.21M | $25.17M | $64.70M | $1.92M |
| High Forecast | $45.02M | $45.02M | $45.02M | $45.02M | $58.78M | $36.10M | $33.92M | $33.92M | $45.63M | $45.95M | $36.23M | $33.98M | $16.10M | $28.76M | $64.60M | $166.02M | $4.93M |
| Low Forecast | $5.51M | $5.51M | $5.51M | $5.51M | $7.19M | $4.42M | $4.15M | $4.15M | $5.59M | $12.57M | $4.43M | $4.16M | $9.66M | $3.52M | $7.91M | $20.32M | $603.72K |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 2.78% | -4.00% | -1.17% | -0.40% | -18.36% |
4 analysts predict ACLX's average Quarter EBITDA for Mar 24 to be $13.24M, with a high of $33.98M and a low of $4.16M. This is -62.97% lower than Arcellx's previous annual EBITDA (Dec 23) of $35.76M.
Arcellx Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 8 | 5 | 4 | 7 | 5 | 6 | 3 | 2 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $19.52M | $-39.34M | $-23.85M | $-27.34M | $-37.41M |
| Avg Forecast | $-40.30M | $-41.77M | $-49.63M | $-44.58M | $-32.26M | $-41.92M | $-40.52M | $-37.61M | $-29.49M | $-17.59M | $-27.77M | $-27.17M | $-28.50M | $-29.41M | $-39.32M | $97.51M | $-52.20M |
| High Forecast | $-4.36M | $-4.52M | $-5.37M | $-4.83M | $-3.49M | $-4.54M | $-4.39M | $-4.07M | $-3.19M | $1.63M | $-3.01M | $-2.94M | $-14.48M | $-3.18M | $-4.26M | $296.01M | $-5.65M |
| Low Forecast | $-122.33M | $-126.80M | $-150.67M | $-135.33M | $-97.94M | $-127.26M | $-123.01M | $-114.19M | $-89.51M | $-26.72M | $-84.29M | $-82.50M | $-49.76M | $-89.28M | $-119.37M | $10.56M | $-158.48M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -0.68% | 1.34% | 0.61% | -0.28% | 0.72% |
Arcellx's average Quarter net income forecast for Mar 24 is $-27.17M, with a range of $-82.50M to $-2.94M. ACLX's average Quarter net income forecast represents a -239.25% decrease compared to the company's last Quarter net income of $19.52M (Dec 23).
Arcellx SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 8 | 5 | 4 | 7 | 5 | 6 | 3 | 2 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $19.37M | $16.01M | $15.54M | $15.44M | $14.06M |
| Avg Forecast | $25.10M | $25.10M | $25.10M | $25.10M | $32.77M | $20.13M | $18.91M | $18.91M | $25.44M | $34.03M | $20.20M | $18.94M | $18.39M | $16.03M | $36.01M | $92.55M | $2.75M |
| High Forecast | $64.41M | $64.41M | $64.41M | $64.41M | $84.08M | $51.64M | $48.52M | $48.52M | $65.28M | $65.73M | $51.83M | $48.60M | $23.03M | $41.14M | $92.40M | $237.48M | $7.06M |
| Low Forecast | $7.88M | $7.88M | $7.88M | $7.88M | $10.29M | $6.32M | $5.94M | $5.94M | $7.99M | $17.98M | $6.34M | $5.95M | $13.82M | $5.04M | $11.31M | $29.07M | $863.62K |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.05% | 1.00% | 0.43% | 0.17% | 5.11% |
Arcellx's average Quarter SG&A projection for Mar 24 is $18.94M, based on 4 Wall Street analysts, with a range of $5.95M to $48.60M. The forecast indicates a -2.19% fall compared to ACLX last annual SG&A of $19.37M (Dec 23).
Arcellx EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 8 | 5 | 4 | 7 | 5 | 6 | 3 | 2 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $-0.00 | $-0.00 | $-0.58 | $-1.03 |
| Avg Forecast | $-0.75 | $-0.78 | $-0.93 | $-0.83 | $-0.60 | $-0.78 | $-0.76 | $-0.70 | $-0.55 | $-0.33 | $-0.52 | $-0.51 | $-0.53 | $-0.55 | $-0.73 | $1.82 | $-0.98 |
| High Forecast | $-0.08 | $-0.08 | $-0.10 | $-0.09 | $-0.07 | $-0.08 | $-0.08 | $-0.08 | $-0.06 | $0.03 | $-0.06 | $-0.05 | $-0.27 | $-0.06 | $-0.08 | $5.53 | $-0.11 |
| Low Forecast | $-2.29 | $-2.37 | $-2.82 | $-2.53 | $-1.83 | $-2.38 | $-2.30 | $-2.13 | $-1.67 | $-0.50 | $-1.58 | $-1.54 | $-0.93 | $-1.67 | $-2.23 | $0.20 | $-2.96 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -0.00% | 0.00% | 0.00% | -0.32% | 1.06% |
According to 4 Wall Street analysts, Arcellx's projected average Quarter EPS for Mar 24 is $-0.51, with a low estimate of $-1.54 and a high estimate of $-0.05. This represents a -127045.00% decrease compared to ACLX previous annual EPS of - (Dec 23).
Arcellx Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| VTYX | Ventyx Biosciences | $2.29 | $33.86 | 1378.60% | Buy |
| DAWN | Day One Biopharmaceuticals | $14.13 | $38.80 | 174.59% | Buy |
| BMEA | Biomea Fusion | $7.85 | $13.67 | 74.14% | Buy |
| AMLX | Amylyx Pharmaceuticals | $2.62 | $3.33 | 27.10% | Buy |
| NUVL | Nuvalent | $87.45 | $107.33 | 22.73% | Buy |
| ACLX | Arcellx | $76.89 | $61.00 | -20.67% | Buy |
ACLX Forecast FAQ
Is Arcellx a good buy?
Yes, according to 7 Wall Street analysts, Arcellx (ACLX) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 7 'Buy' recommendations, accounting for 100.00% of ACLX's total ratings.
What is ACLX's price target?
Arcellx (ACLX) average price target is $61 with a range of $32 to $85, implying a -20.67% from its last price of $76.89. The data is based on 7 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Arcellx stock go up soon?
According to Wall Street analysts' prediction for ACLX stock, the company can go down by -20.67% (from the last price of $76.89 to the average price target of $61), up by 10.55% based on the highest stock price target, and down by -58.38% based on the lowest stock price target.
Can Arcellx stock reach $120?
ACLX's average twelve months analyst stock price target of $61 does not support the claim that Arcellx can reach $120 in the near future.
What are Arcellx's analysts' financial forecasts?
Arcellx's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $98.97M (high $253.94M, low $31.08M), average EBITDA is $63.41M (high $162.72M, low $19.92M), average net income is $-152M (high $-16.495M, low $-462M), average SG&A $90.71M (high $232.76M, low $28.49M), and average EPS is $-2.846 (high $-0.308, low $-8.64). ACLX's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $109.54M (high $281.06M, low $34.4M), average EBITDA is $70.19M (high $180.09M, low $22.04M), average net income is $-176M (high $-19.09M, low $-535M), average SG&A $100.4M (high $257.62M, low $31.53M), and average EPS is $-3.294 (high $-0.357, low $-9.999).
Did the ACLX's actual financial results beat the analysts' financial forecasts?
Based on Arcellx's last annual report (Dec 2023), the company's revenue was $110.32M, which missed the average analysts forecast of $177.82M by -37.96%. Apple's EBITDA was $-89.88M, missing the average prediction of $113.94M by -178.88%. The company's net income was $-70.69M, missing the average estimation of $275.08K by -25798.17%. Apple's SG&A was $66.35M, missing the average forecast of $162.99M by -59.29%. Lastly, the company's EPS was $-0.0015, missing the average prediction of $0.00514 by -129.18%. In terms of the last quarterly report (Dec 2023), Arcellx's revenue was $63.15M, beating the average analysts' forecast of $20.07M by 214.71%. The company's EBITDA was $35.76M, beating the average prediction of $12.86M by 178.15%. Arcellx's net income was $19.52M, missing the average estimation of $-28.5M by -168.47%. The company's SG&A was $19.37M, beating the average forecast of $18.39M by 5.30%. Lastly, the company's EPS was $0.0004, missing the average prediction of $-0.533 by -100.08%